November 13, 2015
Taipei, Taiwan
Taiwan Bio Industry Organization
Patent litigation in the United States differs from that in other countries in many respects, especially in the scope of information opposing parties may demand from each other. Finnegan attorneys experienced in biotechnology and pharmaceutical patent litigation will lead attendees through an in-depth look at the discovery process in U.S. courts using practical examples of discovery that might be taken in a hypothetical case, which will be based on materials to be distributed in advance of the session.
Topics to be discussed include:
The presentation will conclude with a mock deposition of the named inventor in the patent issue in the hypothetical case.
13:15 Registration
13:45 Welcome Remarks
13:50 Part I
Discovery Tools
Preparing for and Responding to Discovery
15:10 Tea Break
15:30 Part II
Mock Deposition
Managing Litigation Costs
16:25 Q&A
16:40 Reception
MCLE Credit:
Finnegan confirms that this activity has been certified for 2.5 hours of California MCLE credit.
For more information, please contact Ms. Nori Chen at (02)2712-7001 Ext. 113
This event is free of charge; space is limited to three registrants per company.
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Ad Law Buzz Blog
“Banning” a Banned Ingredients Claim: NAD’s Application (and Expansion) of the FTC’s Green Guides
March 18, 2024
Articles
Motion to Dismiss: When an Amended Complaint Might Not Moot What You Think
February 29, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.